- Report
- May 2024
- 545 Pages
United States
From €2408EUR$2,690USD£2,103GBP
- Report
- December 2023
- 220 Pages
Global
From €4476EUR$5,000USD£3,909GBP
- Report
- August 2023
- 1500 Pages
Global
From €7832EUR$8,750USD£6,842GBP
- Report
- December 2022
- 211 Pages
Global
From €5371EUR$6,000USD£4,691GBP
- Report
- October 2022
- 348 Pages
Indonesia, Malaysia, Singapore Indonesia, Malaysia, Singapore
From €4476EUR$5,000USD£3,909GBP
- Report
- October 2022
- 220 Pages
United States
From €4476EUR$5,000USD£3,909GBP
- Report
- March 2022
- 312 Pages
Global
From €6266EUR$7,000USD£5,473GBP
- Report
- August 2024
- 71 Pages
Global
From €1253EUR$1,400USD£1,095GBP
- Report
- October 2023
- 155 Pages
Global
From €4028EUR$4,500USD£3,519GBP
- Report
- December 2024
- 197 Pages
Global
From €4431EUR$4,950USD£3,870GBP
- Report
- November 2022
- 295 Pages
Global
From €4431EUR$4,950USD£3,870GBP
- Report
- November 2022
- 155 Pages
Global
From €2014EUR$2,250USD£1,759GBP
- Report
- April 2024
- 115 Pages
United States
From €1611EUR$1,800USD£1,407GBP
- Report
- October 2023
- 377 Pages
Global
From €3760EUR$4,200USD£3,284GBP
- Report
- December 2022
- 260 Pages
Global
From €2148EUR$2,400USD£1,877GBP
- Report
- January 2025
- 150 Pages
Global
From €4162EUR$4,650USD£3,636GBP
- Report
- January 2025
- 159 Pages
Global
From €4162EUR$4,650USD£3,636GBP
- Report
- April 2024
- 121 Pages
Global
From €4162EUR$4,650USD£3,636GBP
- Report
- July 2023
- 152 Pages
Global
From €4162EUR$4,650USD£3,636GBP
- Report
- June 2023
- 186 Pages
Global
From €4162EUR$4,650USD£3,636GBP

The Liquid Biopsy market within the Pharmaceuticals industry is a rapidly growing field of research and development. It is a minimally invasive procedure that uses a sample of blood to detect and monitor cancer. It is used to detect cancer at an early stage, to monitor the progression of the disease, and to assess the effectiveness of treatments. Liquid biopsy can also be used to detect genetic mutations associated with cancer, which can help guide treatment decisions.
The Liquid Biopsy market is expected to grow significantly in the coming years due to its potential to improve patient outcomes and reduce healthcare costs. It is also expected to benefit from advances in technology, such as the development of more sensitive and specific tests.
Some companies in the Liquid Biopsy market include Guardant Health, Exact Sciences, Biocept, and Genomic Health. Show Less Read more